Karoline Thorum Neumann

Karoline Thorum Neumann

Auto-generated profile, based on publicly available information

Karoline Thorum Neumann

Carbon Dioxide Activation Center (CADIAC), Novo Nordisk Foundation CO2 Research Center, Interdisciplinary Nanoscience Center, Department of Chemistry, Aarhus University, Aarhus C, Denmark

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 June 2018 in Journal of Labelled Compounds and Radiopharmaceuticals
Verified
Journal Article
Closed access
PDF file
DNDennis U. Nielsen
Dennis U. Nielsen
KNKaroline T. Neumann
Karoline T. Neumann
ALAnders T. Lindhardt
Anders T. Lindhardt
TSTroels Skrydstrup
Troels Skrydstrup

3 February 2020 in Angewandte Chemie International Edition
Verified
Journal Article
Closed access
PDF file
ADAske S. Donslund
Aske S. Donslund
SPSimon S. Pedersen
Simon S. Pedersen
CGCecilie Gaardbo
Cecilie Gaardbo
KNKaroline T. Neumann
Karoline T. Neumann
LKLee Kingston
Lee Kingston
TSTroels Skrydstrup
Troels Skrydstrup

22 March 2024 in Nature Communications
Verified
Journal Article
Open access
PDF file
GBGabriel M. F. Batista
Gabriel M. F. Batista
RERuth Ebenbauer
Ruth Ebenbauer
CDCraig Day
Craig Day
JBJonas Bergare
Jonas Bergare
KNKaroline T. Neumann
Karoline T. Neumann
TSTroels Skrydstrup
Troels Skrydstrup
Carbon isotope labelling of bioactive molecules is essential for accessing the pharmacokinetic and pharmacodynamic properties of new drug entities. Aryl carboxylic acids represent an important class of structural motifs ubiquitous in pharmaceutically active molecules and are ideal targets for the installation of a radioactive tag employing isotopically labelled CO2. However, direct isotope incorporation via the reported catalytic reductive carboxylation (CRC) of aryl electrophiles relies on excess CO2, which is incompatible with carbon-14 isotope incorporation. Furthermore, the application of some CRC reactions for late-stage carboxylation is limited because of the low tolerance of molecular complexity by the catalysts. Herein, we report the development of a practical and affordable Pd-catalysed electrocarboxylation setup. This approach enables the use of near-stoichiometric 14CO2 generated from the primary carbon-14 source Ba14CO3, facilitating late-stage and single-step carbon-14 labelling of pharmaceuticals and representative precursors. The proposed isotope-labelling protocol holds significant promise for immediate impact on drug development programmes.

7 November 2022 in Nature Chemistry
Verified
Journal Article
Closed access
PDF file
KNKaroline T. Neumann
Karoline T. Neumann
TSTroels Skrydstrup
Troels Skrydstrup

15 February 2023 in Synlett
Verified
Journal Article
Closed access
PDF file
KNKaroline Thorum Neumann
Karoline Thorum Neumann
TSTroels Skrydstrup
Troels Skrydstrup
NCNicklas Pham Corneliussen
Nicklas Pham Corneliussen
EGEbbe Klit Grove
Ebbe Klit Grove
ASAnne-Sofie Oxfeldt Schøler
Anne-Sofie Oxfeldt Schøler
ADAske Skyum Donslund
Aske Skyum Donslund
We report a nickel-catalyzed carbonylative cross-coupling of alkyl zinc reagents with α,α-difluorobromoacetamides to obtain α,α,-difluoro-β-ketoamides in moderate to good yields. The reaction is catalyzed by a bench-stable nickel(II) pincer complex, in contrast to other reports involving palladium catalysts. The carbonylative reaction is performed in a two-chamber system (COware) in which carbon monoxide (CO) is generated ex situ from the solid precursor SilaCOgen, and then consumed in the adjacent chamber. The reaction operates at low temperatures using near-stoichiometric amounts of CO. Isotopically labeled products can be effortlessly accessed, as demonstrated by using 13C-labeled SilaCOgen.

3 January 2024 in Research Square
Verified
Preprint
Open access
PDF file
TSTroels Skrydstrup
Troels Skrydstrup
GBGabriel Batista
Gabriel Batista
RERuth Ebenbauer
Ruth Ebenbauer
JBJonas Bergare
Jonas Bergare
KNKaroline Neumann
Karoline Neumann
CDCraig Day
Craig Day
Carbon isotope labelling of bioactive molecules is a critical step for accessing the pharmacokinetic and pharmacodynamic properties of new drug entities. Aryl carboxylic acids represent an important class of structural motifs commonly found in many pharmaceutically active molecules and are ideal target structures for the installation of a radioactive tag employing isotopically labelled CO2. However, direct isotope incorporation via the reported catalytic reductive carboxylation (CRC) of aryl electrophiles relies on excess CO2, which is incompatible with carbon-14 isotope incorporation. Furthermore, the application of some CRC reactions for late-stage carboxylation is limited because of the low tolerance of molecular complexity by the catalytic systems. Herein, we report the development of a practical and affordable electrochemical CRC setup based on palladium catalysis. This approach enables the use of near-stoichiometric 14CO2 generated from the primary carbon-14 source Ba14CO3, facilitating late-stage and single-step carbon-14 labelling of pharmaceuticals and representative precursors. Further studies provide more details in the mechanistic understanding of this process, allowing CRC to be performed in solvents alternative to DMF. The proposed isotope-labelling protocol holds significant promise for immediate impact on drug development programmes.